` CTX (Crescita Therapeutics Inc) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

CTX
vs
S
S&P TSX Composite Index (Canada)

Over the past 12 months, CTX has underperformed S&P TSX Composite Index (Canada), delivering a return of -24% compared to the S&P TSX Composite Index (Canada)'s +28% growth.

Stocks Performance
CTX vs S&P TSX Composite Index (Canada)

Loading
CTX
S&P TSX Composite Index (Canada)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CTX vs S&P TSX Composite Index (Canada)

Loading
CTX
S&P TSX Composite Index (Canada)
Difference
www.alphaspread.com

Performance By Year
CTX vs S&P TSX Composite Index (Canada)

Loading
CTX
S&P TSX Composite Index (Canada)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Crescita Therapeutics Inc vs Peers

S&P TSX Composite Index (Canada)
CTX
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Crescita Therapeutics Inc
Glance View

Market Cap
8.4m CAD
Industry
Pharmaceuticals

Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. The company is headquartered in Mississauga, Ontario and currently employs 69 full-time employees. The company went IPO on 2016-03-07. The firm offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. The firm operates through three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products in both the Canadian and international markets. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis, MMPE and DuraPeel, on either an exclusive or non-exclusive basis. The Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization (CDMO) infrastructure, and sales of product development services.

CTX Intrinsic Value
0.6 CAD
Undervaluation 25%
Intrinsic Value
Price
Back to Top